Skip to content

Ultrasound-guided Deep and Superficial Serratus Anterior Plane Block

Comparison of Intraoperative Opioid Consumption, Emergence Time and Hemodynamic Stability Between Ultrasound-guided Deep and Superficial Serratus Anterior Plane Block During Video-assisted Thoracoscopic Lobectomy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04252378
Enrollment
56
Registered
2020-02-05
Start date
2019-07-15
Completion date
2020-03-31
Last updated
2020-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain Management, Thoracotomy

Brief summary

This study evaluates the difference of deep and superficial serratus anterior plane block on intraoperative opioid consumption, emergence time and hemodynamic stability in patients undergoing video-assisted thoracic surgery.

Detailed description

Thoracotomy is known as one of the most painful surgery. Thus, there is a development to reduce surgical stress in terms of operation technique, which is video-assisted thoracoscopic surgery. Although it has reduced postoperative pain and complications compared with thoracotomy, VATS is still quite painful operation. Serratus plane block is a novel technique which provide analgesic effect for lateral chest wall by blocking lateral branch of intercostal nerve. Two methods were proposed to target the top and bottom of the serratus anterior muscle. However, the difference of deep and superficial serratus anterior plane block during intraoperative period has not yet been studied. In this study, therefore, the investigators decided to assess the difference of deep and superficial serratus anterior plane block on intraoperative opioid consumption, emergence time and hemodynamic stability in patients undergoing video-assisted thoracic surgery.

Interventions

Deep Serratus Anterior Plane Block was performed just before the start of surgery after anesthetic induction through ultrasound-guidance.

Superficial Serratus Anterior Plane Block was performed just before the start of surgery after anesthetic induction through ultrasound-guidance.

Sponsors

Kyungpook National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* a) American Society of Anesthesiologists (ASA) physical status 1 or 2 * b) age 20-75 years * c) elective three port Video-assisted thoracoscopic surgery (VATS) lobectomy.

Exclusion criteria

* a) a history of drug allergy for opioids or local anesthetics * b) local infection at the injection site and systemic infection * c) coagulopathy * d) difficulty in understanding the study protocol * e) refusal to participate

Design outcomes

Primary

MeasureTime frameDescription
Intraoperative remifentanil consumptionthrough study completion, an average of 1 yearIntraoperative remifentanil consumption will be checked.

Secondary

MeasureTime frameDescription
Emergence timethrough study completion, an average of 1 yearEmergence time is duration between the end of surgery and extubation. Emergence time will be checked.
Systolic blood pressurethrough study completion, an average of 1 yearSystolic blood pressure (mmHg) will be checked
Heart rate (HR) Heart ratethrough study completion, an average of 1 yearHeart rate (beats per minute) will be checked
Dose of rescue drugs used to control blood pressure and HRthrough study completion, an average of 1 yearDose of rescue drugs used to control blood pressure and HR will be checked
Postoperative pain: numeric rating scale30 minutes later operationPostoperative pain will be evaluated using a numeric rating scale (0 being no pain, 10 being worst pain imaginable)

Countries

South Korea

Contacts

Primary ContactJimin Heo
knuhmrc@knu.ac.kr+82-53-420-5430
Backup ContactSaeyoung Kim
saeyoungkim7@gmail.com+82-53-420-5873

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026